Speculative / Open Application (All Teams)
Constructivebio
About this role
Constructive Bio is a pioneering biotechnology startup focused on genome rewriting and genetic code reprogramming technologies to develop innovative biological products. The company aims to transform cells into bio-factories for creating novel molecules with applications across healthcare, research, and materials. It is a rapidly growing, VC-backed spinout from a renowned Cambridge laboratory, committed to scientific excellence and a collaborative culture.
Skills
About Constructivebio
constructive.bioConstructive.bio is a Cambridge, UK synthetic‑biology company (spun out of the MRC Laboratory of Molecular Biology) developing platform technology to manufacture peptide therapeutics. They use whole‑genome‑recoded Syn61 E. coli and an expanded genetic code — enabling incorporation of 300+ non‑canonical amino acids — to biosynthetically produce peptides by fermentation as an alternative to solid‑phase peptide synthesis (SPPS) at industrial scale. The platform targets a range of peptide modalities, including GLP‑1 receptor agonists and antibody‑drug conjugates, with the aim of unlocking new chemistries and lowering cost/complexity of peptide drug manufacturing.
About Constructivebio
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Constructivebio.
Salary
$61k – $82k
per year